Procore is a biotechnology company singly focused on developing solutions that improve the quality of lives of patients suffering from joint and bone diseases. The company’s flagship RegenoGel family is based on proprietary HAProLink technology, a platform technology that links hyaluronic acid to a protein of choice to create a microenvironment for the body to heal itself via natural, gentle cartilage and bone regeneration. RegenoGel products are approved by Israel’s Ministry of Health and have been commercially available since 2016. RegenoGel and the company’s platform technologies are based on the seminal work in biomimetic innovation of Prof. Avner Yayon’s, Procore’s founder.

ProCore Ltd

Org chart

Teams

Offices